stars 1 stars 2 stars 3

Oubari Pharma was founded in 1989 as the first private pharmaceutical company to initiate sterile production in Syria. The Company was producing sterile products under license from European manufacturers such as Rhone Poulenc, Roussel Uclaf, Dr. Mann, and Lisa Pharma. 1994 set a date for Oubari's first exporting initiatives to African and Middle Eastern countries. In 1999, Oubari Pharma became among the first Companies in Syria to be operating on international recognizable standards such as ISO 9001:2008 with highly equipped laboratories and equipment. The year 2000 marked a milestone in the Company history as it relocated its production to a new factory situated in the environmentally and ecologically clean area of Al Zerbeh (20km from Aleppo city). The new premises boasts an area of 50,000 m² of buildings spread over 120,000 m² of land and is tailored to comply with GMP requirements. Today, the Company has a total of 500 personnel with products present in different countries around the world including Syria, Jordan, Algeria, Iraq, Sudan, Yemen, Azerbaijan, Vietnam, Mauritania, Kenya, Libya and Ghana. Its factory is now considered one of the largest in the Middle East with a wide spectrum of pharmaceutical products in sterile, oral, and topical forms.

Oubari Pharma Questions

The Oubari Pharma annual revenue was $100 million in 2026.

Ziad Oubari is the Executive Director of Oubari Pharma.

48 people are employed at Oubari Pharma.

Oubari Pharma is based in Aleppo, Aleppo.

The NAICS codes for Oubari Pharma are [325, 32541, 3254, 32].

The SIC codes for Oubari Pharma are [283, 28].

Top Oubari Pharma Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users